What is this study trying to find out about small-cell lung cancer?

This study is exploring a remote, direct-to-patient approach to improve research participation and bio-specimen collection in adults with small-cell lung cancer. It also looks at patients' preferences and needs when accessing new treatments or supportive care. The research is led by the Addario Lung Cancer Medical Institute and aims to make research more accessible.

Who may be eligible for this small-cell lung cancer clinical trial?

Adults aged 18 or older diagnosed with extensive stage primary small-cell lung cancer or transformed SCLC may be eligible. Participants must be able to read and communicate in English and willing to share medical information and follow study requirements. Please review eligibility criteria for more details.

Is there any cost to participate in this small-cell lung cancer clinical trial?

Study-related care, including sample collection and surveys, is provided at no cost. Personal travel expenses may vary but are generally minimal since participation is remote and does not require visits to clinical sites.

Actively Recruiting

Age: 18Years +

All Genders

ID06486428

A Study to Evaluate a Remote, Decentralized, Direct-to-Patient Strategy for Clinical Research Engagement of Patients With Small Cell Lung Cancer

Led by Addario Lung Cancer Medical Institute · Updated on 2025-08-01

Participants Needed

Research Sites

26 weeks

Total Duration

AI-Summary

What this Trial Is About

Researchers are evaluating a remote, decentralized approach to improve clinical research outreach and engagement for adults with small-cell lung cancer (SCLC). This observational study aims to explore the feasibility of collecting bio-specimens from patients across the USA without in-person visits. It also assesses patient preferences and needs regarding access to new therapies and supportive care through surveys at the start and after three months. Participants diagnosed with extensive stage primary SCLC or transformed SCLC (where non-small cell lung cancer has changed to include SCLC components) will be invited to join. The study involves remote blood sample collection and completion of surveys at baseline and three months. Recruitment and consent processes are managed centrally by study staff via a dedicated webpage and phone hotline. During the study, participants provide medical information to confirm diagnosis and treatment history. Researchers will evaluate the practicality of this decentralized method over 12 months. The study includes self-reported questionnaires about treatment history, quality of life, and care needs. There is no treatment intervention, and participation is remote, allowing patients to contribute from their homes without traveling to clinical sites.

CONDITIONS

Brief Title

Small Cell Lung Cancer Community Engagement to Eliminate Research Discepancies

Who Can Participate

Age: 18Years +

All Genders

Eligibility Criteria

You may qualify if you...

Men or women aged 18 years or older at the time of consent
Ability to read, write, and communicate in English
Provide voluntary informed consent
Willingness to provide clinical and medical information related to cancer diagnosis
Willingness to comply with study requirements
Diagnosis of extensive stage primary small-cell lung cancer or transformed SCLC

You will not qualify if you...

Presence of uncontrolled illnesses, including psychiatric or social conditions that impair study compliance
Previous enrollment in this study
Note: Participation in other clinical trials is allowed and not exclusionary

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 remote visit

Sample Collection

Duration - 3 months

Participants provide blood samples remotely for research purposes.

2 remote sample collections (baseline and Month 3)

Survey Completion

Duration - 3 months

Participants complete questionnaires documenting their diagnosis, treatment history, quality of life, and supportive resource needs.

2 remote surveys (baseline and Month 3)

Long-term Monitoring

Duration - Up to 12 months

Participants are observed to evaluate the feasibility of conducting remote, decentralized clinical research in the SCLC population.

Remote follow-up contacts as needed